newsfilter
← Latest News
GlobeNewswire·

miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.

Acquisition includes clinical stage anti-IGF-1R monoclonal antibody, VRDN-001, intended for the treatment of thyroid eye disease (TED) Company plans to use private placement financing proceeds of...